However, INPP4B-overexpressing ER+ breast cancers cells were more sensitive to pyrvinium treatment when grown in monolayer culture, and combined 4-OHT-pyrvinium treatment significantly enhanced INPP4B-overexpressing ER+ breast cancer cell death. This evidence concerns the gene ESR1 and breast cancer.